Sponsor:
Introgen Therapeutics
Code:
NCT00041626
Conditions
Carcinoma, Squamous Cell
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
INGN 201
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Introgen Therapeutics on 2007-09-11.